It is debated whether subjects with concentric remodeling (CR, normal left ventricular mass index (LVMI) and increased relative wall thickness (RWT)) are at higher cardiovascular risk than those with normal geometry (NG, normal LVMI and RWT). The aim of this study was to perform a meta-analysis of studies evaluating cardiovascular events in subjects with CR and NG according to baseline classification. We searched for articles evaluating cardiovascular outcome in subjects with CR compared with those with NG, and reporting adjusted hazard ratio (HR) and 95% confidence interval (CI). Six studies were included in the meta-analysis. The pooled population consisted of 7465 subjects with CR and NG. During the follow-up, they experienced 852 events. When compared with NG, the overall adjusted HR was 1.36 (95% CI 1.03-1.78) for CR, Po0.03. There was some heterogeneity between studies. Subgroup meta-analysis showed that increased cardiovascular risk in subjects with CR was more relevant in studies evaluating hypertensive and Caucasian subjects and reporting both fatal and non-fatal events. Cardiovascular risk is significantly higher in subjects with CR than in those with NG. This aspect is more evident in studies including hypertensive patients and Caucasian populations and reporting global cardiovascular risk.
Introduction
A spectrum of left ventricular (LV) morphology has been described both in general and hypertensive populations. 1, 2 Usually, on the basis of values of LV mass index (LVMI) and relative wall thickness (RWT, the ratio of wall thickness to LV diameter), four geometric patterns have been reported by echocardiography. 1, 2 These patterns include normal geometry (NG, normal LVMI and RWT), concentric remodeling (CR, normal LVMI and increased RWT), concentric hypertrophy (increased LVMI and RWT) and eccentric hypertrophy (increased LVMI and normal RWT). 1, 2 The prognostic relevance of LV geometry has also been investigated. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Various studies [3] [4] [5] [6] have repeatedly reported that LV hypertrophy is associated with increased cardiovascular risk.
As far as CR is concerned, discordant data have been published in the literature. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Indeed, some studies have reported an increased risk in subjects with CR, 7, [10] [11] [12] [13] [16] [17] [18] [19] [20] 22 whereas others 8, 9, 21 have not. A substantial number of them are prospective studies, [7] [8] [9] [10] [11] [12] [13] [14] [15] 21, 22 but others are cross-sectional 16, 17 or retrospective. [18] [19] [20] In addition, part of prospective studies have some peculiarities, such as lack of adjustment for other covariates, 13 lack of comparison between different LV geometric patterns at baseline 14, 15 or lack of evaluation of cardiovascular events separately. 21 In this context, a meta-analysis might be helpful to better understand the risk profile of CR. To our knowledge, no meta-analysis has been published about this topic up till now.
The aim of this study was to perform a meta-analysis of prospective studies evaluating cardiovascular risk in subjects with CR and NG according to baseline classification and reporting adjusted statistics.
Materials and methods

Search strategy
The authors of this manuscript conducted a literature search through PubMed, Scopus and ISI Web of Knowledge for articles evaluating cardiovascular outcome in subjects with CR, from 1990 up to now. The terms used to identify studies were 'concentric remodeling' or 'left ventricular geometry' and 'prognosis' or 'cardiovascular risk' or 'cardiovascular outcome' or 'cardiovascular events'. Reference lists of included articles were also examined for additional studies. If necessary, supplementary data were obtained through personal contact with the investigators of the selected studies.
Inclusion criteria for entry in the present metaanalysis were: (1) full-text paper published in a peer-reviewed journal; (2) study on adult population; (3) assessment of cardiovascular risk (any cardiovascular end point, that is, composite or separate endpoints) in CR in comparison with NG according to baseline classification; (4) study evaluating hypertensive and/or general populations; (5) study performed by echocardiographic examination; (6) availability of adjusted hazard ratio (HR) and 95% confidence interval (CI) between CR and NG.
The first literature search identified 272 studies, but only 16 (see ref. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] might be eligible for the analysis (studies in specific settings, such as aortic stenosis, chronic kidney disease, post-myocardial infarction and gestational hypertension were excluded). Out of these, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] six studies [7] [8] [9] [10] [11] [12] could be included in the present meta-analysis. One study 13 was excluded because the adjusted HR was not reported, two studies 14, 15 were excluded because groups with CR and NG, according to baseline classification, were not compared, two 16 ,17 because they were cross-sectional studies, three [18] [19] [20] because they were restrospective studies evaluating allcause mortality, one study 21 because did not report adjusted HR for cardiovascular events and one study 22 was excluded because it was performed with magnetic resonance imaging. Selection of publications is summarized in Figure 1 .
Statistical analysis
To address confounding from other risk factors, we used the adjusted HR and 95% CI of the individual studies to calculate the overall adjusted HR and 95% CI, as also previously performed. 23, 24 Three studies 7, 11, 12 reported the adjusted HR for the global population. Three others [8] [9] [10] reported two separate adjusted HRs (one 8 in men and women, one 9 in patients with and without coronary artery disease at baseline, and one 10 for incident coronary artery disease and congestive heart failure). For these studies, [8] [9] [10] the combined adjusted HR and 95% CI were calculated. For one study, 9 the combined HR and 95% CI were calculated and provided by the authors of that study. For this purpose, they calculated: (1) Cox coefficients and s.e. of groups, (2) the weighting factors for groups based on the s.e., (3) the combined coefficient as the sum of weighted coefficients of groups divided by the sum of the two weights, (4) the combined s.e. as the inverse of the squared root of the sum of the two weights, (5) the combined HR and 95% CI based on the combined coefficient and s.e. For the two other studies, 8, 10 the combined HR and 95% CI were calculated by the authors of the present study by using the same procedure. Thus, the adjusted HR of the global population of three studies 7, 11, 12 and the combined adjusted HR of three others [8] [9] [10] were used for the analysis. We used the fixed or the random effects model according to the absence or presence of heterogeneity between studies. 25 Tests of heterogeneity were performed using the Cochrane Q statistic and I 2 statistic. 26 Individual studies were removed one at a time to evaluate the influence of that study on the pooled estimate. If the point estimate of the combined effect size with one study removed was outside the CI of the overall estimate, with all available studies, then that specific study was considered to have an excessive influence on results. Subgroup meta-analysis, which is equivalent to meta-regression with categorical (or categorized) study level variables, was performed to analyze the potential sources of heterogeneity. 27 A funnel plot, Begg and Mazumdar 28 rank correlation test and regression test of Egger et al. 29 for funnel plot asymmetry were used to examine the likely presence of publication bias and small-study effect. Potential adjustment for missing studies was approached by trim and fill method of Duval and Tweedie. 30 Statistical significance was defined as Po0.05 (two-tailed tests). Analyses were carried out using the Comprehensive Meta-Analysis software version 2 (Biostat, Englewood, NJ, USA).
Results
Some characteristics of subjects with NG and CR, and of global populations, are reported in Table 1 . The pooled population of subjects with NG and CR consisted of 7465 subjects. Mean age was higher in subjects with CR than in those with NG in three studies, 7,9,11 similar in one 12 and not reported in two. 8, 10 Prevalence of men was higher in subjects with CR than in those with NG in three studies, 7, 11, 12 similar in one, 8 lower in one 9 and not reported in another one. 10 LVMI was higher in subjects with CR than in those with NG in three studies, 7, 8, 11 lower in two 9, 12 and not reported in one. 10 Three studies 7, 11, 12 evaluated only hypertensive subjects, and three [8] [9] [10] included a variable percentage of normotensive subjects. Four studies 7, 8, 11, 12 evaluated only Caucasian subjects and two studies 9,10 included a variable percentage of Black subjects. There were some differences across the studies about the cutoff value used to define normal LVMI, whereas that used to define normal RWT was quite similar, except in one study. 10 Follow-up characteristics are reported in Table 2 . Mean follow-up ranged from about 3 to 10 years. A composite end point including cardiac, cerebral and peripheral events was evaluated in four studies, 7, 8, 11, 12 cardiac events were evaluated in one study, 10 and cardiac death in another one. 9 Overall, there were 852 events.
The HR for the incidence of events between CR and NG was adjusted for the vast majority of known risk factors in all selected manuscripts. Three studies 7, 8, 11 also adjusted for LVMI values.
We found mild-to-moderate heterogeneity between studies (Q ¼ 8.3, P ¼ 0.14, and I 2 ¼ 39.8%) and the random effects model was used. Figure 2 gives the adjusted HR and 95% CI of the individual studies and of the overall analysis for the incidence of cardiovascular events between CR and NG. The overall adjusted HR was 1.36 (95% CI 1.03-1.78), Po0.03, for CR versus NG.
Sensitivity analysis (Figure 3 ) indicated that none of the studies had an excessive influential effect on the overall estimate. When the study 9 evaluating only cardiac death was excluded, in comparison with NG, the HR for CR was 1.46 (95% CI 1.10-1.93).
When we explored for publication bias and smallstudy effect, the Begg 
Subgroup meta-analysis was performed in the attempt to find possible sources of differences between studies. Random effects meta-analysis, according to study characteristics, is reported in Table 3 . Increased cardiovascular risk in subjects with CR resulted more evident in studies evaluating hypertensive and Caucasian subjects and reporting both fatal and non-fatal events.
Discussion
Various studies [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] have evaluated cardiovascular outcome in subjects with CR. Among prospective studies, 7-15,21,22 most of them 7,10-13,22 indicated, or tended to indicate, greater risk in subjects with CR than in those with NG. Two cross-sectional studies 16, 17 reported higher risk of cerebrovascular disease in subjects with CR than in those with NG. Retrospective evaluations [18] [19] [20] showed increased risk of all-cause mortality in subjects with CR when compared with those with NG. Though the global message seems to suggest an increased risk in These aspects make difficult to draw a conclusion about the topic. We performed the present metaanalysis including prospective studies evaluating cardiovascular outcome in subjects with CR and NG in which adjusted statistics were reported. We showed that cardiovascular risk is significantly higher in subjects with CR than in those with NG. No study appeared to have excessive influence on the overall estimate.
When we explored for possible sources of heterogeneity between studies by subgroup meta-analysis, we found that an increased cardiovascular risk in subjects with CR was more evident in studies including hypertensive and Caucasian subjects and reporting global cardiovascular risk (fatal and nonfatal events). Indeed, one study 9 reporting only cardiac mortality in a predominantly Black population showed that risk tended to be lower in CR than in NG, and another study 8 evaluating a predominantly normotensive population showed a substantial similar risk between subjects with CR and NG. Thus, it could be speculated that the increased Abbreviations: CHD, coronary heart disease; CHF, congestive heart failure; CR, concentric remodeling; NG, normal geometry; PVD, peripheral vascular disease; RF, renal failure; SD, sudden death; SVT, supraventricular tachyarrhythmia (atrial fibrillation, atrial flutter, supraventricular paroxysmal tachycardia); TIA, transient ischemic attack. Figure 2 Adjusted hazard ratio and 95% confidence interval (CI) for the incidence of events between subjects with concentric remodeling and normal geometry. For Verdecchia et al., 7 Pierdomenico et al. 11 and Tovillas-Moran et al., 12 HR and 95% CI are those published for the global study population. For Krumholz et al., 8 HR and 95% CI are combined values between men (HR 0.9, 95% CI 0.6-1.5) and women (HR 1.3, 95% CI 0.7-2.2) calculated according to the procedure reported in the methods. For Ghali et al., 9 HR and 95% CI are combined values between subjects with (HR 0.98, 95% CI 0.49-1.97) and without (HR 0.73, 95% CI 0.28-1.90) coronary artery disease at baseline provided by the authors of the manuscript and calculated according to the procedure reported in the methods. For Gardin et al., 10 HR and 95% CI are combined values between that reported for coronary heart disease (HR 1.57, 95% CI 0.97-2.54) and that reported for congestive heart failure (HR 1.40, 95% CI 0.71-2.76) calculated according to the procedure reported in the methods. 
Cardiovascular risk in concentric remodeling
SD Pierdomenico et al cardiovascular risk associated with CR may be conditioned by blood pressure status and ethnicity and is more evident when total cardiovascular events are taken into account. These data, however, describe the relationship between the effect size and characteristics across the studies, but not within the studies. Thus, they need further investigation and confirmation. 27 It is tempting to speculate what are the reasons by which CR is associated with increased cardiovascular risk. It has been reported that CR is associated with metabolic alterations, 32 impairment of coronary microcirculation, 33 greater extent of coronary artery disease, 34 greater degree of carotid plaque burden 35, 36 and higher extracardiac organ damage. 36 Thus, with respect to NG, CR could be regarded as a marker of higher cardiovascular damage and increased cardiovascular risk. The present study has some limitations. First, all selected studies, 7, 8, [10] [11] [12] but one, 9 evaluated fatal and non-fatal cardiovascular events. The exclusion of the study 9 evaluating only cardiac death did not change results, but reinforced them. Second, in one study 12 supraventricular tachyarrhythmia was included in the end points; however, it had a low occurrence and its impact on the evaluation of the risk ratio was probably negligible. Third, three studies 7, 8, 11 adjusted HR for LVMI values, whereas three others 9,10,12 did not; however, it should be noted that in two of them 9, 12 LVMI values were higher in subjects with NG than in those with CR, suggesting that the HR between CR and NG might have been underestimated. Fourth, the vast majority of selected studies indexed LV mass by body surface area. This method tends to underestimate the prevalence of LV hypertrophy, either concentric or eccentric, in obese subjects. 37, 38 Thus, it cannot be totally excluded that some subjects with concentric LV hypertrophy might have been included in the CR groups or that others with eccentric LV hypertrophy might have been included in the NG groups. Moreover, there were some differences across the studies regarding the cutoff value used to define normal LVMI. Thus, similarly, it cannot be totally excluded that some studies using higher cutoff values might have included some subjects with concentric LV hypertrophy in the CR groups and others with eccentric LV hypertrophy in the NG groups. It remains unclear whether these aspects might have affected results. Fifth, for three studies [8] [9] [10] we used the combined HR of specific subgroups because the adjusted HR of the global population was not available; this aspect, however, does not seem to have substantially influenced results.
In conclusion, cardiovascular risk is significantly higher in subjects with CR than in those with NG. This aspect is more evident in studies evaluating hypertensive and Caucasian subjects and reporting global cardiovascular risk. What is known about this topic K Various studies have investigated cardiovascular risk in subjects with concentric remodeling.
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K However, it remains debated whether they are at higher cardiovascular risk than those with normal geometry.
